AbbVie Inc. (ABBV) stock analysis
In our weekly check, AbbVie Inc. is graded B (A to F). Of 25 checks on debt, profit, cash flow and trend: 18 pass, warnings: 6, red flags: 1.
About AbbVie Inc.
AbbVie Inc. is a Healthcare company (Drug Manufacturers - General) based in the United States, listed on NYSE as ABBV.
What our checks show for ABBV
Red flags
- The dividend takes 117% of profit: little cushion if profit falls.
Warning signs
- The net margin fell by 4.9 points over 5 years, to 15.7%: the company keeps less of each sale as profit.
- Revenue grew only 4.4% a year over the last 3 years.
- Earnings per share fell 4.3% a year over the last 3 years.
- Net profit fell 4.4% a year over the last 3 years.
- The stock has fallen as much as 49% from a peak. Would you have held through that?
- Recovering from its deepest fall took about 2.3 years.
Strengths
- The gross margin is 73.7% and has risen by 4.8 points: pricing power is holding.
- Operating cash flow is 1.94x net profit: the profit arrives as real cash.
- Analysts expect earnings per share to grow about 65.1% a year over the next years.
- Analysts expect the net margin to improve by 24.6 points from today's 15.7%.
- Free cash flow is 28.6% of revenue: cash for dividends, buybacks or growth.
- A large company: market value $522 billion.
Next earnings report: 2027-02-03
Similar companies
JNJ · MRK · NVS · AZN · AMGN · GILD
Questions
What grade does AbbVie Inc. (ABBV) have?
In our weekly check, AbbVie Inc. is graded B (A to F). Of 25 checks on debt, profit, cash flow and trend: 18 pass, warnings: 6, red flags: 1. The grade is a risk check, not a buy or sell recommendation.
What are the main risks of ABBV stock?
This week's biggest flags for AbbVie Inc.: Dividend stretched, Margins falling, Weak revenue growth. In total 7 of 25 checks show a warning or a red flag.
What does AbbVie Inc. do?
AbbVie Inc. is a Healthcare company (Drug Manufacturers - General) based in the United States, listed on NYSE as ABBV.
When does AbbVie Inc. report earnings next?
The next earnings report is expected on 2027-02-03. We re-run the checks every week, so the grade can change after it.
The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.
Updated 2026-11-14
Open the full analysis